Nursing management of targeted therapies for ErbB2 positive breast cancer: developing a quality service

Bucks Knowledge Archive

Nursing management of targeted therapies for ErbB2 positive breast cancer: developing a quality service

Depledge, J
URI: http://hdl.handle.net/123456789/766
Date: 2012-07-18

Abstract:

EGFR Inhibitors in Metastatic Breast Cancer, Glaxo Smith Kline, Stockley Park West, Uxbridge. 15-17 October 2008, Advisory panel member and delivery of a module presentation

Show full item record

Files in this item

Icon
Name: holding document.doc
Size: 126Kb
Format: Microsoft Word
View/Open

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account